(Press-News.org) STANFORD, Calif. — The cells that slough off from a cancerous tumor into the bloodstream are a genetically diverse bunch, Stanford University School of Medicine researchers have found. Some have genes turned on that give them the potential to lodge themselves in new places, helping a cancer spread between organs. Others have completely different patterns of gene expression and might be more benign, or less likely to survive in a new tissue. Some cells may even express genes that could predict their response to a specific therapy. Even within one patient, the tumor cells that make it into circulating blood vary drastically.
The finding underscores how multiple types of treatment may be required to cure what appears outwardly as a single type of cancer, the researchers say. And it hints that the current cell-line models of human cancers, which showed patterns that differed from the tumor cells shed from human patients, need to be improved upon.
The new study, which will be published online May 7 in PLoS ONE, is the first to look at so-called circulating tumor cells one by one, rather than taking the average of many of the cells. And it's the first to show the extent of the genetic differences between such cells.
"Within a single blood draw from a single patient, we're seeing heterogeneous populations of circulating tumor cells," said senior study author Stefanie Jeffrey, MD, professor of surgery and chief of surgical oncology research.
For over a century, scientists have known that circulating tumor cells, or CTCs, are shed from tumors and move through the bloodstreams of cancer patients. And over the past five years, there's been a growing sense among many cancer researchers that these cells — accessible by a quick blood draw — could be the key to tracking tumors non-invasively. But separating CTCs from blood cells is hard; there can be as few as one or two CTCs in every milliliter of a person's blood, mixed among billions of other blood cells.
To make their latest discovery, Jeffrey, along with an interdisciplinary team of engineers, quantitative biologists, genome scientists and clinicians, relied on a technology they developed in 2008. Called the MagSweeper, it's a device that lets them isolate live CTCs with very high purity from patient blood samples, based on the presence of a particular protein — EpCAM — that's on the surface of cancer cells but not healthy blood cells.
With the goal of studying CTCs from breast cancer patients, the team first tested whether they could accurately detect the expression levels of 95 different genes in single cells from seven different cell-line models of breast cancer — a proof of principle since they already knew the genetics of these tumors. These included four cell lines generally used by breast cancer researchers and pharmaceutical scientists worldwide and three cell lines specially generated from patients' primary tumors.
"Most researchers look at just a few genes or proteins at a time in CTCs, usually by adding fluorescent antibodies to their samples consisting of many cells," said Jeffrey. "We wanted to measure the expression of 95 genes at once and didn't want to pool our cells together, so that we could detect differences between individual tumor cells."
So once Jeffrey and her collaborators isolated CTCs using the MagSweeper, they turned to a different kind of technology: real-time PCR microfluidic chips, invented by a Stanford collaborator, Stephen Quake, PhD, professor of bioengineering. They purified genetic material from each CTC and used the high-throughput technology to measure the levels of all 95 genes at once. The results on the cell-line-derived cells were a success; the genes in the CTCs reflected the known properties of the mouse cell-line models. So the team moved on to testing the 95 genes in CTCs from 50 human breast cancer patients — 30 with cancer that had spread to other organs, 20 with only primary breast tumors.
"In the patients, we ended up with 32 of the genes that were most dominantly expressed," said Jeffrey. "And by looking at levels of those genes, we could see at least two distinct groups of circulating tumors cells." Depending on which genes they used to divide the CTCs into groups, there were as many as five groups, she said, each with different combinations of genes turned on and off. And if they'd chosen genes other than the 95 they'd picked, they likely would have seen different patterns of grouping. However, because the same individual CTCs tended to group together in multiple different analyses, these cells likely represent different types of spreading cancer cells.
The diversity, Jeffrey said, means that tumors may contain multiple types of cancer cells that may get into the bloodstream, and a single biopsy from a patient's tumor doesn't necessarily reflect all the molecular changes that are driving a cancer forward and helping it spread. Moreover, different cells may require different therapies. One breast cancer patient studied, for example, had some CTCs positive for the marker HER2 and others lacked the marker. When the patient was treated with a drug designed to target HER2-positive cancers, the CTCs lacking the molecule remained in her bloodstream.
When the team went on to compare the diverse genetic profiles of the breast cancer patients' CTCs with the cells they'd studied from the cell lines, they were in for another surprise: None of the human CTCs had the same gene patterns as any of the cell-line models.
"These models are what people are using for drug discovery and initial drug testing," said Jeffrey, "but our finding suggests that perhaps they're not that helpful as models of spreading cancers." While the human cell-line cells did show diversity between each of the seven cell lines, they didn't fall into any of the same genetic profiles as the CTCs from human blood samples.
These results don't have immediate impacts for cancer patients in the clinic because more work is needed to discover whether different types of CTCs respond to different therapies and whether that will be clinically useful for guiding treatment decisions. But the finding is a step forward in understanding the basic science behind the bits of tumors that circulate in the blood. It's the first time that scientists have used high-throughput gene analysis to study individual CTCs, and opens the door for future experiments that delve even more into the cell diversity. The Stanford team is now working on different methods of using CTCs for drug testing as well as studying the relationship between CTC genetic profiles and cancer treatment outcomes. They've also expanded their work to include primary lung and pancreatic cancers as well as breast tumors.
### The first authors of the study are former postdoctoral scholars Ashley Powell, PhD, and Amir Talasaz, PhD, and research scientist Haiyu Zhang, PhD. The co-senior author is Ronald Davis, PhD, professor of biochemistry. Other Stanford co-authors include Quake; Marc Coram, PhD, assistant professor of health research and policy; former research scientist Glenn Deng, PhD; Fabian Pease, PhD, emeritus professor of electrical engineering; Michael Mindrinos, PhD, senior research scientist; Shanaz Dairkee, PhD, visiting professor; Melinda Telli, MD, assistant professor of medicine; Ranjana Advani, MD, professor of medicine; Robert Carlson, MD, professor of medicine; Joseph Mollick, MD, PhD, clinical instructor of medicine; Shruti Sheth, MD, clinical instructor of medicine; Allison Kurian, MD, assistant professor of medicine; James Ford, MD, associate professor of medicine and of genetics; and Frank Stockdale, MD, PhD, professor emeritus of medicine. The team also collaborated with researchers at Rutgers University, the Cancer Institute of New Jersey and the Simons Center for Systems Biology in New Jersey.
The MagSweeper is licensed by Stanford to the sequencing company Illumina. Jeffrey, Powell, Talasaz, Mindrinos, Pease and Davis receive royalties for their contributions to the technology; Jeffrey said she donated her royalties to a nonprofit.
The work was supported by the National Institutes of Health, the California Breast Cancer Research Grants Program Office of the University of California, the John and Marva Warnock Cancer Research Fund and donations from Andrew and Debra Rachleff and Vladimir and Natalie Ermakoff.
Information about Stanford's Department of Medicine, which also supported the work, is available at http://medicine.stanford.edu.
The Stanford University School of Medicine consistently ranks among the nation's top medical schools, integrating research, medical education, patient care and community service. For more news about the school, please visit http://mednews.stanford.edu. The medical school is part of Stanford Medicine, which includes Stanford Hospital & Clinics and Lucile Packard Children's Hospital. For information about all three, please visit http://stanfordmedicine.org/about/news.html.
Stanford University Medical Center
Not all tumor cells are equal: Stanford study reveals huge genetic diversity in cells shed by tumors
ELSE PRESS RELEASES FROM THIS DATE:
PULLMAN, Wash.—A new study finds that fetal exposure to the plastic additive bisphenol A, or BPA, alters mammary gland development in primates. The finding adds to the evidence that the chemical can be causing health problems in humans and bolsters concerns about it contributing to breast cancer. "Previous studies in mice have demonstrated that low doses of BPA alter the developing mammary gland and that these subtle changes increase the risk of cancer in the adult," says Patricia Hunt, a geneticist in Washington State University's School of Molecular Biosciences. "Some ...
Philadelphia, PA, May 7, 2012 -- Like their healthy peers, children with disabilities may spend too much time in front of a video screen. For children with cerebral palsy (CP), this leads to an even greater risk of being overweight or developing health issues such as diabetes or musculoskeletal disorders. A group of scientists has found that video games such as Nintendo's Wii offer an enjoyable opportunity to promote light to moderate physical activity in children with CP, and may have a role to play in rehabilitation therapy. Their research is published online today ...
New research provides the strongest evidence to date that psychopathy is linked to specific structural abnormalities in the brain. The study, published in Archives of General Psychiatry and led by researchers at King's College London is the first to confirm that psychopathy is a distinct neuro-developmental sub-group of anti-social personality disorder (ASPD). Most violent crimes are committed by a small group of persistent male offenders with ASPD. Approximately half of male prisoners in England and Wales will meet diagnostic criteria for ASPD. The majority of such men ...
New research indicates that domestic horses originated in the steppes of modern-day Ukraine, southwest Russia and west Kazakhstan, mixing with local wild stocks as they spread throughout Europe and Asia. The research was published today, 07 May, in the journal PNAS. For several decades scientists puzzled over the origin of domesticated horses. Based on archaeological evidence, it had long been thought that horse domestication originated in the western part of the Eurasian Steppe (Ukraine, southwest Russia and west Kazakhstan); however, a single origin in a geographically ...
Scientists at the Universities of Birmingham and Warwick have shed new light on how sperm navigate the female reproductive tract, 'crawling' along the channel walls and swimming around corners; with frequent collisions. Research results published today (Tuesday May 8, 2012) in the Proceedings of the National Academy of Sciences of the United States (PNAS) provide fresh insight into how sperm might find their way to the egg that will help to inform future innovation in the struggle to treat infertile couples. Scientists led by Dr Petr Denissenko, of the School of Engineering ...
Television viewing and unhealthy eating habits in U.S. adolescents appear to be linked in a national survey of students in the fifth to 10 th grades, according to a report published in the May issue of Archives of Pediatrics & Adolescent Medicine, a JAMA Network publication. The study is part of the Nutrition and the Health of Children and Adolescents theme issue. Television viewing (TVV) by young people has been associated with unhealthy eating and food choices that may track into early adulthood. Young people in the U.S. fall short of recommendations for whole fruit, ...
A study of mothers and their toddlers suggests that mothers of overweight toddlers often had inaccurate perceptions of their child's body size, according to a report published in the May issue of Archives of Pediatrics & Adolescent Medicine, a JAMA Network publication. The study is part of the Nutrition and the Health of Children and Adolescents theme issue. Feeding behaviors are influenced by perceptions of a child's body size and misperception of a child's size could lead to inappropriate feeding behaviors, such as encouraging a healthy-weight child to eat more, the ...
Biodiversity hot spots -- the world's biologically richest and most threatened locations on Earth -- and high biodiversity wilderness areas -- biologically rich but less threatened -- are some of the most linguistically diverse regions on our planet, according to a team of conservationists. "Results indicate that these regions (hot spots and high biodiversity wilderness areas) often contain considerable linguistic diversity, accounting for 70 percent of all languages on Earth," the researchers report in this today's (May 7) early online edition of the Proceedings of ...
An Australian school-based obesity prevention program for adolescent girls was not associated with statistically significant differences in body mass index (BMI) and other body composition measures, however the small changes may be related to clinically important health outcomes, according to a report published Online First by Archives of Pediatrics & Adolescent Medicine, a JAMA Network publication. The study is part of the Nutrition and the Health of Children and Adolescents theme issue. Obesity prevention is a global health priority because obese youth are at an elevated ...
Surveys of U.S. adolescents suggest that the estimated peak risk of using prescription pain relievers for extramedical use, such as to get high or for other unapproved indications, occurs in mid-adolescence, according to a report published Online First by Archives of Pediatrics & Adolescent Medicine, a JAMA Network publication. Physicians, other prescribing clinicians such as dentists, and public health professionals are aware of recent increasing trends of prescribing pain relievers. Previous research suggests an increased use of these drugs for extramedical use and ...